Johnson & Johnson Loses Big in Latest Talcum Powder Ovarian Cancer Verdict: Jury Awards $415 Million
This week, Johnson & Johnson was ordered to pay $415 million to a California woman who alleged that her ovarian cancer was caused by the company's talc-containing Baby Powder. Eva Echeverria, now hospitalized and in the final stages of her illness, said she used the product daily for most of her life. She was diagnosed with ovarian cancer in 2007.
Pharmaceutical Industry Lobbyist Requests to be Removed From List of Defendants in Talcum Powder Trials
Defendants in current trials over the link between talcum powder and ovarian cancer include Johnson & Johnson, manufacturer of the most popular baby powder, and Imerys Talc America, supplier of the talc used in the product. However, there has been a third named defendant: the Personal Care Products Council (PCPC). Based in Washington D.C., the PCPC is a trade association and lobbying group, representing over 600 companies that manufacture and distribute personal care products.
Johnson & Johnson Presents “4 Important Facts About the Safety of Talc” – But Are They Really Factual?
As the number of lawsuits over talc-containing Baby Powder continues to grow, manufacturer Johnson & Johnson – once “The Most Trusted Brand in America” – has been fighting back in order to convince the public of the safety of their product. To that end, the J&J corporate website now has a page on “4 Important Facts About the Safety of Talc.” But is the information accurate? What are the facts?
Recent news about the talc included in Johnson & Johnson's Baby Powder and its links to ovarian cancer has many women greatly concerned – and rightfully so. Although juries have been finding for the plaintiffs in a number of cases, awarding judgments in the tens of millions of dollars, the New Jersey-based pharmaceutical giant continues to assert that its product is “safe” and there is no proof that talcum powder causes ovarian cancer.
At the end of October, a jury in St. Louis, Missouri, awarded $67.5 million to a plaintiff who stated her ovarian cancer was the result of using Johnson & Johnson Baby Powder – a product containing talc. This is the third loss in a row for the pharmaceutical and health care products company. All three trials were held in a state court in St. Louis. So far, J&J’s total liability amounts to approximately $195 million. Although such awards are often reduced and sometimes even overturned on appeal, the prospects aren't looking good for the defendants.
Talcum powder, a seemingly innocuous, everyday household product for well over a century, has turned deadly for some users. Specifically, for the women who have found themselves victim of ovarian cancer as a result of using talcum powder in the genital region. What manufacturers have known (or should have known) for at least 45 years is that the substance can cause chronic inflammation – a condition that medical science has connected with the development of some types of cancer.
Talcum powder, a seemingly innocuous substance, has been used by women for various personal and household purposes for well over a century. Suddenly, it is now a cause of action by hundreds of plaintiffs who allege a connection between the use of talcum powder and cancer. Why?